You just read:

COPD Asia-Pacific Market - Valued at $7.3 Billion in 2022 - Gradual Transition from ICS Therapies Toward Targeted and Triple Combination Drug Treatments - Research and Markets

News provided by

Research and Markets

Jan 30, 2017, 09:10 ET